King W J, Brooks C J, Holder R, Hughes P, Adu D, Savage C O
Renal Immunobiology, University of Birmingham, UK.
Clin Exp Immunol. 1998 Jun;112(3):539-46. doi: 10.1046/j.1365-2249.1998.00615.x.
ANCA with specificity for myeloperoxidase (MPO) and proteinase 3 (PR3) are present in patients with systemic vasculitis. The aim of this work was to determine whether such patients have T cell responses to these antigens and whether these responses are related to disease activity. Peripheral blood lymphocytes from 45 patients and 19 controls were cultured with ANCA antigens and proliferation measured. The antigens used were heat-inactivated (HI) MPO, HI PR3, native (non-HI) PR3, HI whole alpha-granules, and 25 overlapping peptides covering the entire PR3 sequence. Significant responses to both whole PR3 preparations were seen from patient and control groups, and to the alpha-granules from the patient group. Patients responded at all stages of disease: active, remitting, treated or untreated. Only two patients responded significantly to MPO. Responses were significantly higher with the patient group than the control group to all four whole ANCA antigens. Responses to those PR3 peptides containing epitopes known to be recognized by ANCA were detected from one patient. Thus, these studies demonstrate that T cells from vasculitis patients can proliferate to PR3 and occasionally to associated ANCA antigens. Further, responses may persist even after disease remission has been achieved.
抗髓过氧化物酶(MPO)和蛋白酶3(PR3)的抗中性粒细胞胞浆抗体(ANCA)存在于系统性血管炎患者中。这项研究的目的是确定此类患者是否对这些抗原有T细胞反应,以及这些反应是否与疾病活动相关。将45例患者和19例对照的外周血淋巴细胞与ANCA抗原一起培养并测量增殖情况。使用的抗原是热灭活(HI)MPO、HI PR3、天然(非HI)PR3、HI全α颗粒,以及覆盖整个PR3序列的25个重叠肽段。患者组和对照组对两种完整PR3制剂均有显著反应,患者组对α颗粒有反应。患者在疾病的所有阶段均有反应:活动期、缓解期、治疗或未治疗。只有两名患者对MPO有显著反应。患者组对所有四种完整ANCA抗原的反应均显著高于对照组。从一名患者中检测到对那些含有已知被ANCA识别的表位的PR3肽段的反应。因此,这些研究表明血管炎患者的T细胞可对PR3以及偶尔对相关ANCA抗原发生增殖反应。此外,即使在疾病缓解后反应仍可能持续。